ChiCTR2400086727 版本V1.0 版本创建时间2024/07/09 15:22:12 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2400086727 

最近更新日期:

Date of Last Refreshed on:

2024-07-09 15:22:08 

注册时间:

Date of Registration:

2024-07-09 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

加速间歇爆发模式脉冲刺激治疗慢性意识障碍的疗效研究

Public title:

Effects of accelerated intermittent theta burst stimulation in prolonged disorders of consciousness

注册题目简写:

English Acronym:

研究课题的正式科学名称:

加速间歇爆发模式脉冲刺激治疗慢性意识障碍的疗效研究

Scientific title:

Effects of accelerated intermittent theta burst stimulation in prolonged disorders of consciousness

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

邹乐瑶 

研究负责人:

冯珍 

Applicant:

Leyao Zou  

Study leader:

Zhen Feng 

申请注册联系人电话:

Applicant telephone:

+86 137 5580 8895

研究负责人电话:

Study leader's telephone:

+86 139 7003 8111

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

lyzou825@163.com

研究负责人电子邮件:

Study leader's E-mail:

fengzhenly@sina.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

江西省南昌市东湖区永外正街17号

研究负责人通讯地址:

江西省南昌市东湖区永外正街17号

Applicant address:

No.17, Yongwaizheng Street, Donghu District, Nanchang City, Jiangxi Province

Study leader's address:

No.17, Yongwaizheng Street, Donghu District, Nanchang City, Jiangxi Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

南昌大学第一附属医院

Applicant's institution:

The First Affiliated Hospital of Nanchang University

研究负责人所在单位:

南昌大学第一附属医院

Affiliation of the Leader:

The First Affiliated Hospital of Nanchang University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

IIT[2023]临伦审第266号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

南昌大学第一附属医院医学伦理委员会

Name of the ethic committee:

Medical Ethics Committee of the First Affiliated Hospital of Nanchang University

伦理委员会批准日期:

Date of approved by ethic committee:

2023-09-14 00:00:00

伦理委员会联系人:

舒展

Contact Name of the ethic committee:

Zhan Shu

伦理委员会联系地址:

江西省南昌市东湖区永外正街17号

Contact Address of the ethic committee:

No.17, Yongwaizheng Street, Donghu District, Nanchang City, Jiangxi Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 791 8869 2201

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

南昌大学第一附属医院

Primary sponsor:

The First Affiliated Hospital of Nanchang University

研究实施负责(组长)单位地址:

江西省南昌市东湖区永外正街17号

Primary sponsor's address:

No.17, Yongwaizheng Street, Donghu District, Nanchang City, Jiangxi Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江西

市(区县):

南昌

Country:

China

Province:

Jiang Xi

City:

Nan Chang

单位(医院):

南昌大学第一附属医院

具体地址:

江西省南昌市东湖区永外正街17号

Institution
hospital:

The First Affiliated Hospital of Nanchang University

Address:

No.17, Yongwaizheng Street, Donghu District, Nanchang City, Jiangxi Province

经费或物资来源:

自筹

Source(s) of funding:

self-finance

Target disease:

the prolonged disorders of consciousness

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

探索性研究/预试验 

Study phase:

0

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

探索加速间歇爆发模式脉冲刺激(aiTBS)治疗慢性意识障碍的有效性,为加速间歇爆发模式脉冲刺激治疗慢性意识障碍提供高质量的支持。  

Objectives of Study:

Exploring the effectiveness of Accelerated Intermittent Theta Burst Stimulation (aiTBS) in the treatment of the prolonged consciousness disorders, to provide high-quality support for the use of aiTBS in accelerating the treatment of the prolonged consciousness disorders.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1、年龄≥18岁; 2、生命体征稳定; 3、慢性意识障碍患者:VS、MCS;

Inclusion criteria

1.Age ≥ 18 years. 2.Stable vital signs. 3.Patients with chronic consciousness disorders: Vegetative State (VS) or Minimally Conscious State (MCS).

排除标准:

1、妊娠 2、颅内压升高 3、活动性脑出血 4、治疗靶区颅骨缺损 5、癫痫病史或脑电图癫痫样活动 6、植入起搏器、深部脑刺激器、动脉瘤夹或冠状动脉支架

Exclusion criteria:

1.Pregnancy. 2.Increased intracranial pressure. 3.Active cerebral hemorrhage. 4.Cranial bone defects in the treatment target area. 5.History of epilepsy or epileptiform activity on electroencephalogram (EEG). 6. Implantation of pacemakers, deep brain stimulators, aneurysm clips, or coronary artery stents.

研究实施时间:

Study execute time:

From 2023-10-06 00:00:00 To 2025-02-28 00:00:00  

征募观察对象时间:

Recruiting time:

From 2023-10-06 00:00:00 To 2024-10-31 00:00:00  

干预措施:

Interventions:

组别:

试验组

样本量:

34

Group:

trail group

Sample size:

干预措施:

加速间歇爆发模式脉冲刺激

干预措施代码:

Intervention:

accelerated intermittent theta burst stimulation

Intervention code:

组别:

对照组

样本量:

34

Group:

control group

Sample size:

干预措施:

假刺激

干预措施代码:

Intervention:

sham stimulation

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

江西 

市(区县):

南昌 

Country:

China 

Province:

Jiang Xi 

City:

Nan Chang 

单位(医院):

南昌大学第一附属医院 

单位级别:

三甲 

Institution
hospital:

The First Affiliated Hospital of Nanchang University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

改良昏迷恢复量表

指标类型:

主要指标

Outcome:

the Coma Recovery Scale –Revised, CRS-R

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

全面无反应量表评分

指标类型:

次要指标

Outcome:

FOUR scores

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

运动行为工具修订版评估

指标类型:

次要指标

Outcome:

MBT-r assessment

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

脑电图频谱

指标类型:

次要指标

Outcome:

EEG spectrum

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

静息态近红外脑功能成像

指标类型:

次要指标

Outcome:

resting fNIRS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

扩展版格拉斯哥结果量表评分

指标类型:

次要指标

Outcome:

GOS-E scores

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 90 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由中心分组人员采用统计软件SPSS 26中的“随机数字生成器”语句生成随机分配序列,将符合标准的患者按纳入顺序编号随机分为aiTBS治疗组和对照组。

Randomization Procedure (please state who generates the random number sequence and by what method):

Center personnel used the 'Random Number Generator' statement in statistical software SPSS 26 to generate a random allocation sequence. Eligible patients were assigned sequential numbers based on their inclusion order and were randomly allocated into the trail group and the control group.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

对受试者、评估者设盲

Blinding:

Blinding subjects and evaluators

是否共享原始数据:

IPD sharing

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

https://redcap.jxskfyxh.org.cn/index.php

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

https://redcap.jxskfyxh.org.cn/index.php

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据记录于REDCap系统中,平台链接:https://redcap.jxskfyxh.org.cn/index.php

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Data recorded in the RedCap system,the website is 'https://redcap.jxskfyxh.org.cn/index.php'

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2024-07-09 15:22:08